Evidence map›Paper›PMID 37470917›Full record

ArticleTranslational stroke research2024

Clopidogrel Is Associated with Reduced Likelihood of Aneurysmal Subarachnoid Hemorrhage: a Multi-Center Matched Retrospective Analysis.

Joseph S Hudson, Kamil W Nowicki, Brandon Lucke-Wold, Zachary C Gersey, William S Dodd, Ali Alattar, David J McCarthy, Prateek Agarwal, Zain Mehdi, Michael J Lang and 3 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Translational stroke research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Joseph S HudsonDepartment of Neurosurgery, University of Pittsburgh Medical Center, 200 Lothrop Street, 4th floor, Pittsburgh, PA, USA. hudsonjs@upmc.edu.
Kamil W NowickiDepartment of Neurosurgery, University of Pittsburgh Medical Center, 200 Lothrop Street, 4th floor, Pittsburgh, PA, USA.
Brandon Lucke-WoldDepartment of Neurosurgery, College of Medicine, University of Florida, Gainesville, FL, USA.
Zachary C GerseyDepartment of Neurosurgery, University of Pittsburgh Medical Center, 200 Lothrop Street, 4th floor, Pittsburgh, PA, USA.
William S DoddDepartment of Neurosurgery, College of Medicine, University of Florida, Gainesville, FL, USA.
Ali AlattarDepartment of Neurosurgery, University of Pittsburgh Medical Center, 200 Lothrop Street, 4th floor, Pittsburgh, PA, USA.
David J McCarthyDepartment of Neurosurgery, University of Pittsburgh Medical Center, 200 Lothrop Street, 4th floor, Pittsburgh, PA, USA.
Prateek AgarwalDepartment of Neurosurgery, University of Pittsburgh Medical Center, 200 Lothrop Street, 4th floor, Pittsburgh, PA, USA.
Zain MehdiUniversity of Iowa Carver College of Medicine, Iowa City, IA, USA.
Michael J LangDepartment of Neurosurgery, University of Pittsburgh Medical Center, 200 Lothrop Street, 4th floor, Pittsburgh, PA, USA.
David M HasanDepartment of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Brian L HohDepartment of Neurosurgery, College of Medicine, University of Florida, Gainesville, FL, USA.
Bradley A GrossDepartment of Neurosurgery, University of Pittsburgh Medical Center, 200 Lothrop Street, 4th floor, Pittsburgh, PA, USA.
University of Pittsburgh Medical Center · USUniversity of Florida · USDuke Medical Center · USUniversity of Iowa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maladaptive inflammation underlies the formation and rupture of human intracranial aneurysms. There is a growing body of evidence that anti-inflammatory pharmaceuticals may beneficially modulate this process. Clopidogrel (Plavix) is a commonly used irreversible P2Y12 receptor antagonist with anti-inflammatory activity. In this paper, we investigate whether clopidogrel is associated with the likelihood of aneurysm rupture in a multi-institutional propensity-matched cohort analysis. Patients presenting for endovascular treatment of their unruptured intracranial aneurysms and those presenting with aneurysm rupture between 2015 and 2019 were prospectively identified at two quaternary referral centers. Patient demographics, comorbidities, and medication usage at the time of presentation were collected. Patients taking clopidogrel or not taking clopidogrel were matched in a 1:1 fashion with respect to location, age, smoking status, aneurysm size, aspirin usage, and hypertension. A total of 1048 patients with electively treated aneurysms or subarachnoid hemorrhages were prospectively identified. Nine hundred twenty-one patients were confirmed to harbor aneurysms during catheter-based diagnostic angiography. A total of 172/921 (19%) patients were actively taking clopidogrel at the time of presentation. Three hundred thirty-two patients were matched in a 1:1 fashion. A smaller proportion of patients taking clopidogrel at presentation had ruptured aneurysms than those who were not taking clopidogrel (6.6% vs 23.5%, p < .0001). Estimated treatment effect analysis demonstrated that clopidogrel usage decreased aneurysm rupture risk by 15%. We present, to the best of our knowledge, the first large-scale multi-institutional analysis suggesting clopidogrel use is protective against intracranial aneurysm rupture. It is our hope that these data will guide future investigation, revealing the pathophysiologic underpinning of this association.

Indexed as

Aneurysm, RupturedClopidogrelIntracranial AneurysmPlatelet Aggregation InhibitorsSubarachnoid HemorrhageAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesClopidogrelPlatelet Aggregation InhibitorsAneurysmClopidogrelInflammationStrokeSubarachnoid hemorrhage

Identifiers

PMID37470917
OpenAlexW4384819799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.